45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Sarah Sultan Al Rubaish, MD

Research Fellow
H. Lee Moffitt Cancer Center
12902 Magnolia Dr
Tampa, FL
USA 33612

Papers:
54 - Featured Poster Development of a Rucaparib response signature that shows in vitro predictive value to the PARP inhibitors, ABT-888 and Olaparib in ovarian cancer cells 301 - Poster Session A HSP90 inhibition decreases ovarian cancer cell proliferation and potentiates platinum sensitivity